Just want to mention that Solartech posted a reve
Post# of 22456
1. His projection uses 214 million tests which could happen cumulatively, but would take more than a few years which he says himself..
More likely the number of tests is more like what the 3 test manufacturers can output per year which would be considerably less. Of course, other test manufacturers may join and other organizations with their own access to tests could join QDX HealthID.
2. Earnings per share would be less than his projection with less tests, but it also doesn't take into consideration repeat testing and the SaaS, which would be recurring revenue.
3. Finally, I think once there is revenue, a Price/Earning Ratio can be projected, and an appropriate Tech/Biotech/Coronavirus related P/E applied. All 3 industries are high growth so I think 20 P/E is moderate. Its hard to believe the P/E ratios on tech companies in the current stock market climate. Whats the P/E for Tesla at $2000/share???
https://www.cnet.com/roadshow/news/tesla-stock-share-price/
All the above is speculation, I am not expert in the computations of above factors, Not investment advice. Ted will probably rip it to shreds, and thats Ok. FWIW. Have a great day.